Suchergebnisse - "O'Connor, Owen A"

PubPharm (20)

1

Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance

enthalten in: BMC cancer | 2021

von Oiwa, K. | Hosono, N. | Nishi, R. | +3

2

Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers

enthalten in: Genes, chromosomes & cancer | 2020

von Scotto, L. | Kinahan, C. | Casadei, B. | +9

3

A peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder : efficacy of pralatrexate in primary refractory disease and review of the literature

enthalten in: Leukemia & lymphoma | 2019

von Ma, H. | Bhagat, G. | O'Connor, O.

4

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma

enthalten in: Blood | 2018

von Amengual, J. | Lichtenstein, R. | Lue, J. | +15

CommentIn: Blood. 2018 Jan 25;131(4):375-376. - PMID 29371206

5

Pralatrexate : a comprehensive update on pharmacology, clinical activity and strategies to optimize use

enthalten in: Leukemia & lymphoma | 2017

von O'Connor, O. | Amengual, J. | Colbourn, D. | +2

6

Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma

enthalten in: Hematology/oncology clinics of North America | 2017

von Marchi, E. | Raufi, A. | O'Connor, O.

7

Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Zullo, K. | Guo, Y. | Cooke, L. | +10

8

Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Jain, S. | Jirau-Serrano, X. | Zullo, K. | +15

9

Pralatrexate pharmacology and clinical development

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2013

von Marchi, E. | Mangone, M. | Zullo, K. | +1

10

Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides : a subgroup efficacy analysis from the PROPEL study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2012

von Foss, F. | Horwitz, S. | Coiffier, B. | +9